Back to CGEM
UBS Group AG CGEM Position History
Cullinan Therapeutics, Inc. • Healthcare
Quarters held
15
Latest value
$138
Q3 2026
Peak value
$2.4M
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $690K |
| Q3 2025 | $426K |
| Q4 2025 | $1.3M |
| Q4 2025 | $739K |
| Q4 2025 | $819K |
| Q1 2026 | $1.7M |
| Q1 2026 | $1.1M |
| Q2 2026 | $2M |
| Q2 2026 | $2.4M |
| Q2 2026 | $60K |
| Q2 2026 | $15K |
| Q3 2026 | $1.7M |
| Q3 2026 | $1.6M |
| Q3 2026 | $219K |
| Q3 2026 | $138 |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $138 | 9 | — | — |
| Q3 2026 | $219K | 14.2K | — | — |
| Q3 2026 | $1.6M | 104.2K | — | — |
| Q3 2026 | $1.7M | 110.8K | — | — |
| Q2 2026 | $15K | 821 | — | — |
| Q2 2026 | $60K | 3.3K | — | — |
| Q2 2026 | $2.4M | 133.4K | — | — |
| Q2 2026 | $2M | 111.1K | — | — |
| Q1 2026 | $1.1M | 80.7K | — | — |
| Q1 2026 | $1.7M | 121.7K | — | — |
| Q4 2025 | $819K | 79.2K | — | — |
| Q4 2025 | $739K | 71.4K | — | — |
| Q4 2025 | $1.3M | 121.2K | — | — |
| Q3 2025 | $426K | 71.8K | — | — |
| Q3 2025 | $690K | 116.4K | — | — |
Other funds holding CGEM
$177.2M
$163.2M
$163.2M
$149.2M
$137.6M
$127.4M
$108.7M
$104.7M